356 related articles for article (PubMed ID: 16696133)
1. Women's Health Initiative: not over yet. The largest study of women's health has raised at least as many questions as it has answered. Stay tuned.
Harv Womens Health Watch; 2006 May; 13(9):1-4. PubMed ID: 16696133
[No Abstract] [Full Text] [Related]
2. Abbreviated hormone replacement therapy trial answers some questions, raises new ones. The Women's Health Initiative is no longer testing the most widely prescribed estrogen and progestin combination--but the study's job is far from over.
Harv Womens Health Watch; 2002 Oct; 10(2):2-4. PubMed ID: 12393317
[No Abstract] [Full Text] [Related]
3. Hormone therapy. A year in review.
Mayo Clin Womens Healthsource; 2003 Aug; 7(8):1-2. PubMed ID: 12925832
[TBL] [Abstract][Full Text] [Related]
4. Combination hormone therapy tied to slight increase in breast cancer deaths.
Mayo Clin Womens Healthsource; 2011 Mar; 15(3):3. PubMed ID: 21301403
[No Abstract] [Full Text] [Related]
5. The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits--an attempt to interpret the Women's Health Initiative results.
Kuhl H; Stevenson J
Gynecol Endocrinol; 2006 Jun; 22(6):303-17. PubMed ID: 16785155
[TBL] [Abstract][Full Text] [Related]
6. Pharmacologic deficiency in the Women's Health Initiative Study.
Stanczyk FZ; Chaikittisilpa S; Roy S
J Reprod Med; 2003 Jun; 48(6):485-6. PubMed ID: 12856527
[No Abstract] [Full Text] [Related]
7. Use of combination hormone replacement therapy in light of recent data from the Women's Health Initiative.
Kaunitz AM;
Medscape Womens Health; 2002; 7(4):8. PubMed ID: 12466740
[No Abstract] [Full Text] [Related]
8. The Women's Health Initiative Randomized Trials and Clinical Practice: A Review.
Manson JE; Crandall CJ; Rossouw JE; Chlebowski RT; Anderson GL; Stefanick ML; Aragaki AK; Cauley JA; Wells GL; LaCroix AZ; Thomson CA; Neuhouser ML; Van Horn L; Kooperberg C; Howard BV; Tinker LF; Wactawski-Wende J; Shumaker SA; Prentice RL
JAMA; 2024 May; 331(20):1748-1760. PubMed ID: 38691368
[TBL] [Abstract][Full Text] [Related]
9. Women's health. The vanishing promises of hormone replacement.
Enserink M
Science; 2002 Jul; 297(5580):325-6. PubMed ID: 12130763
[No Abstract] [Full Text] [Related]
10. [After the early termination of the Women's Health Initiative study. New American recommendations for postmenopausal hormone therapy].
Stjernquist M;
Lakartidningen; 2003 May; 100(20):1790-7. PubMed ID: 12806859
[TBL] [Abstract][Full Text] [Related]
11. Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin.
Anderson GL; Chlebowski RT; Rossouw JE; Rodabough RJ; McTiernan A; Margolis KL; Aggerwal A; David Curb J; Hendrix SL; Allan Hubbell F; Khandekar J; Lane DS; Lasser N; Lopez AM; Potter J; Ritenbaugh C
Maturitas; 2006 Sep; 55(2):103-15. PubMed ID: 16815651
[TBL] [Abstract][Full Text] [Related]
12. Impact of WHI conclusions and ACOG guidelines on clinical practice.
Gass M
Int J Fertil Womens Med; 2003; 48(3):106-10; discussion 137-8. PubMed ID: 12839140
[TBL] [Abstract][Full Text] [Related]
13. The Women's Health Initiative.
Nabel EG
Science; 2006 Sep; 313(5794):1703. PubMed ID: 16990517
[No Abstract] [Full Text] [Related]
14. Termination of the oestrogen-alone arm of the Women's Health Initiative.
Stevenson J; Rees M; Marsden J
J Br Menopause Soc; 2004 Jun; 10(2):47, 59. PubMed ID: 15759323
[No Abstract] [Full Text] [Related]
15. The Women's Health Initiative estrogen plus progestin trial: the study and how it changes our practice.
Hendrix SL
J Am Osteopath Assoc; 2003 Feb; 103(2 Suppl 2):S3-5. PubMed ID: 12625631
[No Abstract] [Full Text] [Related]
16. Good science or good marketing?
Head K
Altern Med Rev; 2002 Aug; 7(4):274-5. PubMed ID: 12197780
[No Abstract] [Full Text] [Related]
17. [Health symptom-free women do not need preventive hormone replacement therapy. The risks outweigh the benefits; a large trial prematurely interrupted in the USA].
von Schoultz B
Lakartidningen; 2002 Aug; 99(34):3276-8. PubMed ID: 12362844
[No Abstract] [Full Text] [Related]
18. A personal initiative for women's health: to challenge the Women's Health Initiative.
Genazzani AR; Gambacciani M
Gynecol Endocrinol; 2002 Aug; 16(4):255-7. PubMed ID: 12396552
[No Abstract] [Full Text] [Related]
19. ACOG Committee Opinion No. 420, November 2008: hormone therapy and heart disease.
American College of Obstetricians and Gynecologists Committee on Gynecologic Practice
Obstet Gynecol; 2008 Nov; 112(5):1189-92. PubMed ID: 18978127
[TBL] [Abstract][Full Text] [Related]
20. [Conjugated estrogen-gestagen does not reduce cardiovascular morbidity. Were these findings (in the Women's Health Initiative study) really unexpected?].
Henriksson P
Lakartidningen; 2002 Nov; 99(47):4716-9. PubMed ID: 12523045
[No Abstract] [Full Text] [Related]
[Next] [New Search]
